CytRx Corporation s in-depth stock price analysis indicates that the stock price has dropped -28.47% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -30.99% . Looking at the past 52 week period, the stock price is down -83.42% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of CytRx Corporation has a negative value of -86.11 compared to overall market performance. CytRx Corporation (NASDAQ:CYTR) has tumbled 3.13% during the past week and has dropped 13.63% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 3.91%. CytRx Corporation (NASDAQ:CYTR) has underperformed the index by 15.17% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
CytRx Corporation (NASDAQ:CYTR) : On Friday heightened volatility was witnessed in CytRx Corporation (NASDAQ:CYTR) which led to swings in the share price. The stock opened for trading at $0.417 and hit $0.427 on the upside , eventually ending the session at $0.4146, with a gain of 0.05% or 0.0002 points. The heightened volatility saw the trading volume jump to 1,213,720 shares. The 52-week high of the share price is $3.66 and the company has a market cap of $45 million. The 52-week low of the share price is at $0.361 .
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.